Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein-Reference-Cited by-同舟云学术

Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein

Published:2010-07-16 Issue:15 Volume:53 Page:5467-5475
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Fruttero Roberta¹,Crosetti Marco¹,Chegaev Konstantin¹,Guglielmo Stefano¹,Gasco Alberto¹,Berardi Francesco²,Niso Mauro²,Perrone Roberto²,Panaro Maria Antonietta³,Colabufo Nicola Antonio²

Affiliation:

1. Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Via Pietro Giuria 9, 10125 Torino, Italy

2. Dipartimento Farmacochimico, Facoltá di Farmacia, Università degli Studi di Bari “A. Moro”, Via Orabona, 4, 70125 Bari, Italy

3. CIMAOL, Università degli Studi di Bari “A. Moro”, Piazza Giulio Cesare, 70124 Bari, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm100066y

Reference42 articles.

1. Mechanisms of Cancer Drug Resistance

2. Cell biological mechanisms of multidrug resistance in tumors.

3. Mining our ABCs

4. Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06

2. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

3. Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery;Drug Metabolism Reviews;2022-03-07

4. Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition;Pharmaceuticals;2022-02-18

5. Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents;European Journal of Medicinal Chemistry;2022-02